Global Big Pharma, Big Dividends

Hisamitsu Pharmaceutical

Market Cap: JP¥303.1b

Manufactures and sells pharmaceuticals in Japan.

Kyowa Kirin

Market Cap: JP¥1.2t

Engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally.

Astellas Pharma

Market Cap: JP¥2.5t

Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.

Yunnan Baiyao GroupLtd

Market Cap: CN¥101.0b

Engages in the pharmaceutical business in China, Southeast Asia, Europe, the United States, Japan, and internationally.

Ipsen

Market Cap: €8.4b

Operates as a biopharmaceutical company worldwide.

Zydus Lifesciences

Market Cap: ₹914.3b

Engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally.

J. B. Chemicals & Pharmaceuticals

Market Cap: ₹265.1b

Manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.

Lupin

Market Cap: ₹903.7b

Operates as a pharmaceutical company in India and internationally.

Zoetis

Market Cap: US$72.1b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.

Shenzhen Hepalink Pharmaceutical Group

Market Cap: CN¥15.1b

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Zhangzhou Pientzehuang Pharmaceutical

Market Cap: CN¥123.9b

Engages in the manufacture and sale of Chinese medicines under the Pien Tze Huang brand in China and internationally.

Beijing Tongrentang

Market Cap: CN¥51.6b

Engages in the scientific research, production, distribution, and sale of Chinese medicines in China.

Changchun High-Tech Industry (Group)

Market Cap: CN¥41.3b

Researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China.

Ipca Laboratories

Market Cap: ₹370.4b

A pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, CIS, and Australasia.

Novo Nordisk

Market Cap: DKK 2.0t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Torrent Pharmaceuticals

Market Cap: ₹1.1t

Engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.

Jilin Aodong Pharmaceutical Group

Market Cap: CN¥19.0b

Jilin Aodong Pharmaceutical Group Co., Ltd.

Gland Pharma

Market Cap: ₹251.9b

Engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally.

Pfizer

Market Cap: ₹235.5b

Engages in manufacturing, marketing, trading, and export of pharmaceutical products in India and internationally.

Recordati Industria Chimica e Farmaceutica

Market Cap: €10.6b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

Alkem Laboratories

Market Cap: ₹632.3b

A pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.

Otsuka Holdings

Market Cap: JP¥3.5t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Zhejiang Huahai Pharmaceutical

Market Cap: CN¥24.9b

Operates as a pharmaceutical company in China and internationally.

H. Lundbeck

Market Cap: DKK 35.6b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

GSK

Market Cap: UK£57.8b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Viatris

Market Cap: US$10.0b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Chugai Pharmaceutical

Market Cap: JP¥12.4t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Daiichi Sankyo Company

Market Cap: JP¥7.0t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

Sino Biopharmaceutical

Market Cap: HK$74.8b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

Hypera

Market Cap: R$15.4b

Operates as a pharmaceutical company in Brazil.

Alembic Pharmaceuticals

Market Cap: ₹191.1b

Develops, manufactures, and markets pharmaceutical products in India and internationally.

Yifan Pharmaceutical

Market Cap: CN¥15.1b

Engages in the researches and develops, produces, and sells macromolecules, biosimilars, generic drugs, small molecules, synthetic biologics, and special traditional Chinese medicines in China Southeast Asia, Europe, North America, Singapore, South Korea, Italy, Germany, and the United States, and internationally.

Shanghai Fosun Pharmaceutical (Group)

Market Cap: CN¥57.6b

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

CSPC Pharmaceutical Group

Market Cap: HK$75.7b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

Dong-E-E-JiaoLtd

Market Cap: CN¥36.0b

Research and development, production, and sale of Ejiao and a series of Chinese patent medicines, health foods, and foods.

Hubei Jumpcan Pharmaceutical

Market Cap: CN¥25.0b

Engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based Chinese traditional medicines, and Chinese medicine health products in China.